Table: Cosmos Pharmaceutical -2024/25 parent results

Cosmos Pharmaceutical

11/07/2025 07:30

Jul 11 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              May 31, 2025    May 31, 2024   May 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales         1.01 trln        964.99                                
               (+4.8 pct)      (+16.6 pct)                             
  Operating       40.39           31.48                                
               (+28.3 pct)     (+4.6 pct)                              
  Recurring       43.16           34.29                                
               (+25.9 pct)     (+3.7 pct)                              
  Net             30.98           24.45                                
               (+26.7 pct)     (+2.8 pct)                              
  EPS          390.83 yen      308.51 yen                              
  Ann Div       70.00 yen      120.00 yen      75.00 yen               
  -Q2 Div       32.50 yen       60.00 yen      37.50 yen               
  -Q4 Div       37.50 yen       60.00 yen      37.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T